CP, which is a potential oncogenic factor, is aberrantly expressed in various malignancies like lung cancer (Tsai et al., 2020), ovarian cancer (Dai et al., 2020), and hepatic cancer (Shang et al., 2020), and can be involved in tumor growth and metastasis by regulating ferroptosis, angiogenesis, and tumor microenvironment (TME). This evidence concerns the gene CP and ovarian cancer.